Table.
Results of Routine CSF Tests and Anti-MOG Antibody Titer Tests at Different Timepoints in the Patient’s Clinical Course.
| CSF | Serum | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cells (/μL) |
Protein (mg/dL) |
IL-6 (pg/mL) |
IgG-index | MBP | MOG Ab titers | MOG Ab titers | ||||||||
| 1st admission (during EPC) |
4 | 25 | NA | 0.59 | Negative | 1:16 | NA | |||||||
| 2nd admission (before treatment) |
21 | 26 | 37.9 | 0.66 | Negative | 1:8 | 1:128 | |||||||
| 2nd admission (after treatment) |
8 | 22 | NA | 0.66 | Negative | Undetectable | 1:512 | |||||||
CSF: cerebrospinal fluid, EPC: epilepsia partialis continua, IL-6: interleukin-6, MBP: myelin basic protein, MOG: myelin oligodendrocyte glycoprotein, MOG Ab: anti-MOG antibody, NA: not analyzed